leisure time -WSS

leisure time

author：knowledge 2025-09-30 17:59:33 - browse：1

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Emergency workers more likely to restrain Black patients: study

hotspot

WSS

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Microbiome research is starting to find links to chronic diseases

A Theranos scientist

A Theranos scientist

Johnson & Johnson sues to stop Medicare negotiation

A look at other Americans who have crossed into North Korea over the years

explore

leisure time

hotspot

Continuity nursing helped my family in our darkest PICU moments

ER docs worry over extreme heat as a 'mass casualty event'

In age of alternative facts, a scholarly course on calling out crap

15 die by electrocution after transformer explodes in northern India

Anesthesiologist group: stop taking Ozempic before surgery

How AI helped researchers track recovery from depression

Hollywood unions extend contract negotiations for actors

Intarcia’s device

Heart attack and stroke risk calculators need revising

STAT Virtual Event: Putting AI to the Test

explore

What Congress can do to address the rural doctor shortage

Changes to biosimilar regulatory framework must prioritize patients

15 die by electrocution after transformer explodes in northern India

Johnson & Johnson sues to stop Medicare negotiation

Study: Hearing aids may slow cognitive decline in those at risk

FDA seeking to stop procedures at two unregulated stem cell clinics

hotspot

focus

hotspot

focus